Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation

Mar.09
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
China Tobacco Hubei Industrial Co., Ltd. has published a patent describing a laboratory method to evaluate the reproductive and developmental safety of heated tobacco products using non-human animal exposure models. The approach introduces a structured toxicological testing framework that could support safety verification, quality control, and regulatory evidence generation for heated tobacco products.

Key Points

 

  • A new patent proposes an animal-based testing method to assess reproductive and developmental safety of heated tobacco exposure.
  • The method constructs controlled exposure models using Wistar rats and aerosol extracts from heated tobacco products.
  • Multiple indicators—including hormone levels, sperm quality, and offspring development—are used for safety evaluation.
  • The framework may help generate scientific evidence for product safety verification and regulatory submissions.

 

 

2Firsts, March 9, 2026

 

According to publicly available information on the patent database of China’s National Intellectual Property Administration (CNIPA), China Tobacco Hubei Industrial Co., Ltd., a subsidiary of China National Tobacco Corporation (CNTC), disclosed a patent titled “Method for Evaluating Reproductive and Developmental Safety Based on a Non-Human Animal Heated Cigarette Exposure Model.”

 

The patent application (No. 202511512948.X) was filed on October 22, 2025, and published on January 6, 2026 under publication number CN121275990A.

 

The invention outlines a structured experimental model designed to evaluate the potential reproductive and developmental effects of exposure to aerosols generated by heated tobacco products (HTPs).

 

Construction of a Heated Tobacco Exposure Model

 

The proposed method begins with the collection of aerosol particulate matter generated during the heating of tobacco sticks. These aerosols are condensed, dissolved, sterilized, and diluted to produce a smoke extract solution used for animal exposure experiments.

 

Researchers then construct non-human animal exposure models, typically using Wistar rats, which receive the aerosol extract via gavage over a defined exposure period. After exposure, animals are bred with untreated counterparts to observe potential reproductive outcomes.

 

This design allows researchers to simulate long-term exposure scenarios and evaluate whether aerosol constituents affect reproductive function or offspring development.

 

Multi-Dimensional Biological Indicators

 

The patent emphasizes the use of multiple biological indicators to evaluate reproductive and developmental safety.

 

Key measurements include:

 

Parental reproductive indicators

 

  • Testosterone synthesis and hormonal levels
  • Sperm density, motility, and morphology

 

Offspring developmental indicators

 

  • Litter size and sex ratio
  • Body weight and body length
  • Placental development metrics
  • Blood biochemical indicators such as endocrine and metabolic markers

 

These indicators allow researchers to assess both parental reproductive health and offspring developmental outcomes following heated tobacco exposure.

 

Experimental Benchmarking Against Reference Products

 

The patent describes comparative experiments using reference heated tobacco products considered “safety standard products,” including internationally marketed heated tobacco sticks.

 

Experimental groups exposed to aerosol extracts from different heated tobacco samples were compared with control groups receiving water. The reported results indicated no significant abnormalities in reproductive or developmental indicators, suggesting comparable outcomes across groups under the tested conditions.

 

Industry Implications

 

Safety evaluation remains a key issue in the regulatory landscape for next-generation nicotine products. While heated tobacco products typically generate fewer harmful constituents than combustible cigarettes, regulators continue to require toxicological and long-term health evidence before allowing market entry in many jurisdictions.

 

The method described in this patent illustrates how Chinese tobacco research institutions are developing structured preclinical testing frameworks for heated tobacco products. Such experimental models could support:

 

  • product safety validation
  • toxicological research
  • regulatory submissions in international markets
  • internal quality control during product development

 

As the global heated tobacco market expands and regulatory scrutiny intensifies, standardized evaluation methods may become increasingly important for both manufacturers and regulators.

 

More updates on the global next-generation nicotine industry are available at 2Firsts.

 

Cover Image source:CNIPA

Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04